TY - JOUR
T1 - The ASTCT-NMDP ACCESS Initiative
T2 - A Collaboration to Address and Sustain Equal Outcomes for All across the Hematopoietic Cell Transplantation and Cellular Therapy Ecosystem
AU - ACCESS Workshop Team
AU - Auletta, Jeffery J.
AU - Sandmaier, Brenda M.
AU - Jensen, Erica
AU - Majhail, Navneet S.
AU - Knutson, Jessica
AU - Nemecek, Eneida
AU - Ajayi-Hackworth, Femina
AU - Davies, Stella M.
N1 - Publisher Copyright:
© 2022 The American Society for Transplantation and Cellular Therapy
PY - 2022/12
Y1 - 2022/12
N2 - The American Society for Transplantation and Cellular Therapy (ASTCT) and the National Marrow Donor Program (NMDP) have formed the ACCESS Initiative to address and reduce barriers to hematopoietic cell transplantation (HCT) and cellular therapy (CT) in an effort to ensure equal access and outcomes for all patients in need. In addition to cellular therapy physicians, the initiative includes program administrators, health policy and health equity experts, health service researchers, participants from commercial payer organizations, and federal stakeholders. The inaugural ASTCT-NMDP ACCESS Workshop was held in Washington, DC on July 28 and 29, 2022, wherein committee members met to discuss and to define goals for 3 focus areas: awareness, poverty, and racial and ethnic inequity. This position paper reviews the mission, vision, and structure of the ACCESS Initiative and the proceedings from the inaugural workshop and provides an initial roadmap for the group's efforts at reducing access barriers and outcome disparities in HCT/CT.
AB - The American Society for Transplantation and Cellular Therapy (ASTCT) and the National Marrow Donor Program (NMDP) have formed the ACCESS Initiative to address and reduce barriers to hematopoietic cell transplantation (HCT) and cellular therapy (CT) in an effort to ensure equal access and outcomes for all patients in need. In addition to cellular therapy physicians, the initiative includes program administrators, health policy and health equity experts, health service researchers, participants from commercial payer organizations, and federal stakeholders. The inaugural ASTCT-NMDP ACCESS Workshop was held in Washington, DC on July 28 and 29, 2022, wherein committee members met to discuss and to define goals for 3 focus areas: awareness, poverty, and racial and ethnic inequity. This position paper reviews the mission, vision, and structure of the ACCESS Initiative and the proceedings from the inaugural workshop and provides an initial roadmap for the group's efforts at reducing access barriers and outcome disparities in HCT/CT.
KW - Access barriers
KW - Bone marrow transplantation
KW - CAR T cell
KW - Cell therapy
KW - Chimeric antigen receptor T cell
KW - Equality
KW - Ethnicity
KW - Hematopoietic cell transplantation
KW - Outcomes
KW - Poverty
KW - Racial inequity
KW - Structural racism
UR - http://www.scopus.com/inward/record.url?scp=85140963672&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85140963672&partnerID=8YFLogxK
U2 - 10.1016/j.jtct.2022.09.020
DO - 10.1016/j.jtct.2022.09.020
M3 - Article
C2 - 36184058
AN - SCOPUS:85140963672
SN - 2666-6375
VL - 28
SP - 802
EP - 809
JO - Transplantation and Cellular Therapy
JF - Transplantation and Cellular Therapy
IS - 12
ER -